Apollo to Present at the UBS Financial Services Conference

(NYSE:APO), NEW YORK, Feb. 02, 2026 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) today announced that Martin Kelly, Chief Financial Officer, will participate in a fireside chat at the UBS Financial Services Conference on Tuesday, February 10, 2026 at 8:50 am ET. A live webcast of the event will be available on Apollo's Investor Relations website […]

Living in California Releases 2026 Guide to Living in Los Angeles, a practical, data-informed resource designed to help future residents understand the realities of life in LA

Irvine, CA, Feb. 02, 2026 (GLOBE NEWSWIRE) — As interest in California relocation continues into 2026, Los Angeles remains one of the most researched and most misunderstood cities in the country. To help prospective residents move beyond assumptions and headlines, Living in California has released a new 2026 Guide to Living in Los Angeles, offering

EURneffy(R) 1 mg (adrenaline nasal spray) Recommended for Approval in the EU for Emergency Treatment of Type 1 Allergic Reactions, including Anaphylaxis in Children Weighing greater-than or equal to15 kg to <30 kg

(NasdaqGM:SPRY), EURneffy 1 mg will be the first and only needle-free adrenaline available to younger children in the European Union ARS Pharma's partner, ALK-Abello A/S, who owns the rights to market EURneffy in the EU, will distribute following expected authorization by the European Commission SAN DIEGO, Feb. 02, 2026 (GLOBE NEWSWIRE) — ARS Pharmaceuticals, Inc.

Flock Safety Engages Bishop Fox to Set the Industry Standard in Cybersecurity for its Public Safety Platform

Atlanta, GA, Feb. 02, 2026 (GLOBE NEWSWIRE) — Flock Safety, the leading safety technology platform dedicated to creating thriving communities, and Bishop Fox, the leading authority in offensive security, will launch a comprehensive testing campaign to provide third-party evaluation of Flock's technology as part of the company's continued commitment to security and risk management. This

vTv Therapeutics Amends License Agreement with Newsoara Biopharma Co. Ltd. for PDE4 inhibitor, HPP737

(NASDAQ:VTVT), Strategic amendment transforms regional partnership into global collaboration; Newsoara gains exclusive worldwide license to develop and commercialize novel PDE4 inhibitor vTv to receive $20 million upfront payment immediately upon execution of the amended license agreement HIGH POINT, N.C., Feb. 02, 2026 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company focused

First Merchants Corporation Completes Legal Closing of First Savings Financial Group Merger

(NASDAQ:FRME),(NASDAQ:FSFG), MUNCIE, Ind., Feb. 02, 2026 (GLOBE NEWSWIRE) — First Merchants Corporation (NASDAQ: FRME) and First Savings Financial Group, Inc. (NASDAQ: FSFG) have finalized a merger of the two companies. Following regulatory approvals last month, the companies consummated their legal closing through a stock transaction effective February 1, 2026. As previously announced in late 2025,

ORYZON Strengthens Patent Portfolio for Vafidemstat With New Decision to Grant in Japan

(Madrid:ORY.MC),(Boerse Stuttgart – Freiverkehr:ORN),(Madrid:ORY),(Boerse Stuttgart – Freiverkehr:ORN.SG), For the treatment of aggression and social withdrawal MADRID and CAMBRIDGE, Mass., Feb. 02, 2026 (GLOBE NEWSWIRE) — Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a global leader in epigenetics, today announced that it has received a “Decision to grant” communication from the

Aqua Metals to Participate in NAATBatt 2026 Annual Meeting in Tucson; Discuss Commercial and Technical Milestones in Domestic Battery Materials

(NASDAQ:AQMS), RENO, Nev., Feb. 02, 2026 (GLOBE NEWSWIRE) — Aqua Metals, Inc. (NASDAQ: AQMS), a pioneer in sustainable battery metals recycling and refining, today announced that members of its executive and technical teams will participate in the NAATBatt 2026 Annual Meeting, taking place February 9-12, 2026, in Tucson, Arizona. The NAATBatt Annual Meeting brings together

Abinopharm, Inc. Releases AbinoNutra(R) NMN White Paper Following FDA Reinstatement and Human Clinical Trial Evidence

SHELTON, Conn., Feb. 02, 2026 (GLOBE NEWSWIRE) — Abinopharm, Inc., a U.S.-based life-science company headquartered in Shelton, Connecticut, today announced the publication of its newly released AbinoNutra(R) NMN White Paper, detailing the scientific rationale, quality standards, safety profile, and human clinical trial data supporting AbinoNutra(R) NMN as a premium nutritional ingredient for healthy aging. B-Nicotinamide

Kaltura Recognized as a Notable Vendor in Virtual Event Management Platforms Landscape Report by the Leading Analyst Firm

(NASDAQ:KLTR), New York, Feb. 02, 2026 (GLOBE NEWSWIRE) — Kaltura, the AI Video Experience Cloud, today announced that it has been named as a Notable Vendor in Forrester's 'Virtual Event Management Platforms Landscape' report. For Kaltura, the recognition highlights their comprehensive AI-powered virtual event solutions that support enterprises in delivering immersive, engaging, and impactful experiences,

Scroll to Top